COVID-19 Lung Findings Detected by 68Ga-PSMA PET/CT for Staging Purposes in Patients With Prostate Cancer
Articles > Article · 2021
Authors: Burcin Karasah Erkek, Özgür Ömür, Serdar Özkök, Burak Turna
Clinical Nuclear Medicine, International, WoS, 2021, vol 47, pp e17-e19
DOI: 10.1097/rlu.0000000000003723
Summary
ABSTRACT: We report 3 patients with COVID-19 findings in 68Ga-PSMA PET/CT taken for staging. The first patient, A 64-year-old man with prostate cancer, who had COVID-19 in November 2020 and whose treatment was completed, was observed to continue with COVID-19 findings in 68Ga-PSMA PET/CT in December 2020 before surgery. Other patients were asymptomatic for the disease. It was determined that a PSMA uptake in the lungs corresponding to the CT findings of COVID-19 had increased in 68Ga-PSMA PET/CT.